Keyphrases
Acute Respiratory Distress Syndrome
7%
Adaptive Immune Response
5%
Adipose-derived Stromal Cells
9%
Autoimmune Disease
9%
Cardiovascular Disease
5%
CD8+ T Cells
5%
Cell Therapy
13%
Cell-based
8%
Chilean
5%
Chronic Kidney Disease
13%
Clinical Diagnosis
5%
Differentiation Potential
5%
Disease Activity
7%
Early Rheumatoid Arthritis
8%
Endometrial Stem Cells
14%
Etiology
5%
Experimental Autoimmune Encephalomyelitis
14%
Graft-versus-host Disease (GvHD)
5%
Group A Streptococcus
6%
Heart Failure Patients
10%
Human Mesenchymal Stem Cells (hMSCs)
17%
Human Umbilical Cord Mesenchymal Stromal Cells
8%
Immunomodulatory Properties
5%
Immunosuppressive Properties
6%
Inflammatory Response
6%
Intensive Care Medicine
5%
Interleukin-17 (IL-17)
13%
Intravenous Infusion
6%
Latin American
5%
Mesenchymal Stem Cell Therapy
13%
Mesenchymal Stem Cells
86%
Mesenchymal Stromal Cells
11%
MicroRNA
5%
Mitochondrial Transfer
8%
Myocardial Infarction
5%
Organ Damage
5%
Patients with Heart Failure
5%
Phase II Trial
7%
Randomized Clinical Trial
5%
Rat Model
13%
Regulatory T Cells
5%
Remission Induction
5%
Rheumatic Diseases
5%
Rheumatic Fever
12%
Rheumatic Heart Disease
13%
Rheumatoid Arthritis
14%
Rheumatoid Arthritis Patients
5%
Secreted Factors
5%
Sepsis
6%
Stem Cell Therapy
10%
Stem Cell-derived
6%
Stem Cells
10%
Systemic Lupus Erythematosus
21%
Systemic Lupus Erythematosus Patient
9%
T Cells
20%
T Helper 17 (Th17)
26%
Th1 Cells
11%
Therapeutic Effect
5%
Thrombocytopenia
5%
Tissue Damage
8%
Toll-like
8%
Transplantation
5%
Valvular
9%
Immunology and Microbiology
Adipose Tissue
8%
Arthritis
8%
Autoimmune Disease
12%
Bone Marrow Derived Mesenchymal Stem Cell
10%
CD25
5%
CD4
9%
Cell Population
7%
Cytokine
10%
Cytotoxic T-Cell
6%
Experimental Autoimmune Encephalomyelitis
14%
Graft-Versus-Host Disease
5%
Immune System
5%
Immunity
9%
Immunocompetent Cell
5%
Immunosuppressive Drug
21%
Inflammation Response
6%
Inflammatory Arthritis
9%
Interleukin 6
6%
Lupus Erythematosus
6%
Mesenchymal Stem Cell
100%
Mesenchymal Stem Cell Transplantation
7%
Rat Model
13%
Regulatory T Cell
16%
Rheumatic Disease
5%
Rheumatic Heart Disease
8%
Stem Cell
14%
Stem Cell Transplantation
5%
Systemic Lupus Erythematosus
21%
T Cell
22%
T Cell Activation
5%
T-Helper Cell
9%
Th1 Cell
11%
Th17 Cell
17%
Toll-Like Receptor
5%
Umbilical Cord
6%
Medicine and Dentistry
Acute Respiratory Distress Syndrome
7%
Adipose Tissue
9%
Autoimmune Disease
6%
Bone Marrow Derived Mesenchymal Stem Cell
10%
Cardiovascular Disease
5%
Carditis
5%
Cell Therapy
11%
Congestive Heart Failure
6%
Cytotoxic T-Cell
5%
Disease
22%
Experimental Autoimmune Encephalomyelitis
5%
Heart Disease
5%
Hemodialysis
7%
Immunity
5%
Immunosuppressive Drug
5%
Infection
10%
Intravenous Drug Administration
5%
Mesenchymal Stem Cell
43%
Mesenchymal Stem Cell Transplantation
7%
microRNA
5%
Programmed Cell Death
5%
Quality of Life
6%
Randomized Clinical Trial
5%
Randomized Controlled Trial
5%
Receptor
8%
Rheumatic Fever
12%
Rheumatic Heart Disease
13%
Stem Cell
17%
Stem Cell Therapy
5%
Streptococcus Group A
6%
Stromal Cell
9%
Systemic Lupus Erythematosus
18%
T Cell
14%
Umbilical Cord
10%